Unjha Formulations (BOM:531762) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531762 Unjha Formulations Ltd BOM:531762
77 GF Score
Price ₹26.50
GF Value ₹22.81
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Unjha Formulations Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:531762 vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Unjha Formulations's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Unjha Formulations Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unjha Formulations's Short Interest distribution charts can be found below:

* The bar in red indicates where Unjha Formulations's Short Interest falls into.


BOM:531762
77GF Score
Unjha Formulations Ltd BOM:531762
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Unjha Formulations (BOM:531762) Overvalued in 2026?

Based on GuruFocus' analysis, Unjha Formulations stock appears to be overvalued. The current stock price of ₹26.50 is trading 16.2% above its estimated GF Value™ of ₹22.81. GuruFocus considers Unjha Formulations to be Modestly Overvalued.

Key valuation signals for BOM:531762:

  • Short Interest:
  • GF Value™: ₹22.81 vs. price of ₹26.50 (16.2% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the BOM:531762 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unjha Formulations Business Description

Address Khali Char Rasta, State Highway, Sidhpur, Khali, Patan, GJ, IND, 384151
Unjha Formulations Ltd is an India-based manufacturer and exporter of Ayurvedic products. The company products include Isabgol powder under the Fibron and Fibron SF name, and Sat-Isabgol and Isabgol Husk. It also offers human and veterinary medicines.
77GF Score

Get the complete analysis for BOM:531762

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹26.50
Price
₹22.81
GF Value